Comorbidities and its Effects on COVID-19 Patients Attribute Mortalities at CMH Attock

Comorbidities and Covid- 19

Abstract

Objective: The aim of this Study was to assess the comorbidities in the severe acute respiratory syndrome
coronavirus (COVID-19) infected patients and the risk of underlying diseases in more severe patients compared
to moderate or mild symptomatic patients.
Study Design: Retrospective study.
Place and Duration of Study: The study was conducted at isolated treatment facility ward of COVID-19 of
Combined Military Hospital CMH, Attock, Pakistan from March 2020 to October 2021.
Materials and Methods: The study comprised of a total of 389 confirmed COVID-19 positive cases out of 1990
reported cases which included 28 deaths due to comorbid illnesses. Patients were divided in two groups,one
group having co-morbidities and other group with no comorbidity.
Results: There were 389 COVID-19 infected confirmed cases,including 28 deaths of severely ill patients. The
deaths were mainly associated with comorbidities and were reported in CMH Attockfrom March 2020 to October 2021.Symptoms included fever followed by cough, fatigue, and dyspnea. The most common comorbidities were hypertension and diabetes, followed by cardiovascular disease and diseases of the respiratory system.
Conclusion: We assessed the prevalence of comorbidities in the COVID-19 patients and concluded that
underlying diseases, including hypertension, diseases of respiratory system and cardiovascular diseases, may be risk factors for death inmore severe patients on contrary to moderately or mildly symptomatic patients.

How to cite this: Saeed I, Ali A, Awan AS, Manzoor, Iffet S. Comorbidities and Its Effects in COVID-19 Patients Attribute Mortalities at CMH Attock. 2022; 3(4): 188-191. doi: http://doi.org/10.37185/LnS.1.1.247